GRAIL Raises $900M For Cancer Detection Efforts
Menlo Park-based GRAIL, announced this morning that it has raised $900M in a first close of a planned, $1 billion funding round. The Series B funding was led by Arch Venture Partners, and included Johnson and Johnson Innovation, Amazon, Bristol-Myers Squibb, Celgene, McKesson Ventures, Merck, Tencent Holdings, and Varian Medical Systems. GRAIL is a spinout of life sciences equipment maker Illumina, which spun the startup out in January of last year.
posted on Wednesday, March 1, 2017
Related companies:
GRAIL
Related stories:
> Grail Gets $300M More For Cancer Detection Testing
> Grail Nears $1 Billion In Series B
> WSJ: Facebook For $900M?
> Cloudera Raises $900M In Mega Financing Round
> Battery Ventures Raises $900M In Two Funds
silicontap.com Home